F. Fano

770 total citations
25 papers, 544 citations indexed

About

F. Fano is a scholar working on Surgery, Internal Medicine and Physiology. According to data from OpenAlex, F. Fano has authored 25 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Internal Medicine and 6 papers in Physiology. Recurrent topics in F. Fano's work include Diagnosis and Treatment of Venous Diseases (13 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Thermoregulation and physiological responses (4 papers). F. Fano is often cited by papers focused on Diagnosis and Treatment of Venous Diseases (13 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Thermoregulation and physiological responses (4 papers). F. Fano collaborates with scholars based in Italy, Germany and Austria. F. Fano's co-authors include M R Cesarone, Mark Dugall, A. Di Renzo, M. Cacchio, L Pellegrini, A. Ricci, Stefano Stuard, G. Vinciguerra, E. Ippolito and A Ledda and has published in prestigious journals such as Phytotherapy Research, Phytomedicine and Redox Report.

In The Last Decade

F. Fano

25 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Fano Italy 15 211 155 94 89 62 25 544
I. Ruffini Italy 14 190 0.9× 173 1.1× 72 0.8× 57 0.6× 51 0.8× 25 510
Andrea Ledda Italy 16 148 0.7× 58 0.4× 162 1.7× 82 0.9× 173 2.8× 65 825
A. Di Renzo Italy 23 484 2.3× 428 2.8× 143 1.5× 141 1.6× 126 2.0× 51 1.2k
Morio Hosoi Italy 10 80 0.4× 41 0.3× 52 0.6× 46 0.5× 89 1.4× 61 429
Bertram Ottillinger Germany 12 160 0.8× 64 0.4× 58 0.6× 11 0.1× 40 0.6× 25 457
Pedro Zorrilla Spain 9 244 1.2× 96 0.6× 16 0.2× 186 2.1× 109 1.8× 10 568
G Cipollone Italy 8 58 0.3× 8 0.1× 53 0.6× 39 0.4× 56 0.9× 19 272
Vincenzo Aiello Italy 7 63 0.3× 19 0.1× 27 0.3× 19 0.2× 347 5.6× 24 690
Rodrigo González United States 22 1.1k 5.4× 43 0.3× 18 0.2× 46 0.5× 28 0.5× 37 1.5k
Muhammad Zafar Irshad Khan Pakistan 12 39 0.2× 47 0.3× 30 0.3× 9 0.1× 126 2.0× 27 473

Countries citing papers authored by F. Fano

Since Specialization
Citations

This map shows the geographic impact of F. Fano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Fano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Fano more than expected).

Fields of papers citing papers by F. Fano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Fano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Fano. The network helps show where F. Fano may publish in the future.

Co-authorship network of co-authors of F. Fano

This figure shows the co-authorship network connecting the top 25 collaborators of F. Fano. A scholar is included among the top collaborators of F. Fano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Fano. F. Fano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosoi, Morio, Gianni Belcaro, Andrea Ledda, et al.. (2018). Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study. 69(3). 4 indexed citations
2.
Bottari, Antonio, Gianni Belcaro, A Ledda, et al.. (2012). Lady Prelox® improves sexual function in post-menopausal women.. PubMed. 54(1 Suppl 4). 6 indexed citations
3.
Cesarone, M R, Gianni Belcaro, Peter Rohdewald, et al.. (2010). Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol®: A prospective, controlled study. Phytomedicine. 17(11). 835–839. 28 indexed citations
4.
Belcaro, G, M R Cesarone, Umberto Cornelli, et al.. (2010). Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study.. PubMed. 52(4). 269–75. 3 indexed citations
5.
Belcaro, Gianni, M R Cesarone, Silvia Errichi, et al.. (2008). Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol®. Redox Report. 13(6). 271–276. 37 indexed citations
6.
Belcaro, Gianni, M R Cesarone, Silvia Errichi, et al.. (2008). Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo‐arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects. Phytotherapy Research. 22(4). 518–523. 51 indexed citations
7.
Vinciguerra, G., G Belcaro, Cesarone Mr, et al.. (2008). Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study.. PubMed. 56(5 Suppl). 47–53. 2 indexed citations
8.
Cesarone, M R, G Belcaro, Lucienne Pellegrini, et al.. (2008). Treatment of ankle sprain in patients with vascular diseases of the lower limbs.. PubMed. 56(5 Suppl). 39–46. 3 indexed citations
9.
Cesarone, M R, G Belcaro, Massimiliano Marco Corsi Romanelli, et al.. (2007). Local Heparin, Superficial Vein Thrombosis. Angiology. 58(1S). 36S–40S. 7 indexed citations
10.
Cesarone, M R, Gianni Belcaro, Silvia Errichi, et al.. (2007). Topical Heparin: New Observations. Angiology. 58(1S). 16S–20S. 4 indexed citations
12.
Cesarone, M R, Gianni Belcaro, Silvia Errichi, et al.. (2007). Microcirculatory Effects of Viatromb® Spray Gel Heparin in Chronic Venous Insufficiency: Evaluation of TcPO2 and PCO2—A Product Evaluation Study. Angiology. 58(1S). 21S–26S. 4 indexed citations
13.
Cesarone, M R, Gianni Belcaro, A. Di Renzo, et al.. (2007). Prevention of Influenza Episodes With Colostrum Compared With Vaccination in Healthy and High-Risk Cardiovascular Subjects. Clinical and Applied Thrombosis/Hemostasis. 13(2). 130–136. 30 indexed citations
14.
Belcaro, Gianni, M R Cesarone, B.M. Errichi, et al.. (2006). Diabetic Ulcers: Microcirculatory Improvement and Faster Healing With Pycnogenol. Clinical and Applied Thrombosis/Hemostasis. 12(3). 318–323. 33 indexed citations
15.
Cesarone, M R, Gianni Belcaro, L Pellegrini, et al.. (2006). Circulating Endothelial Cells in Venous Blood as a Marker of Endothelial Damage in Chronic Venous Insufficiency: Improvement with Venoruton. Journal of Cardiovascular Pharmacology and Therapeutics. 11(1). 93–99. 16 indexed citations
16.
Cesarone, M R, Gianni Belcaro, Peter Rohdewald, et al.. (2006). Improvement of Diabetic Microangiopathy With Pycnogenol®: A Prospective, Controlled Study. Angiology. 57(4). 431–436. 38 indexed citations
17.
Cesarone, M R, Gianni Belcaro, Peter Rohdewald, et al.. (2006). Comparison of Pycnogenol® and Daflon® in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study. Clinical and Applied Thrombosis/Hemostasis. 12(2). 205–212. 47 indexed citations
18.
Cesarone, M R, Gianni Belcaro, L Pellegrini, et al.. (2006). Venoruton® vs Daflon®: Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency. Angiology. 57(2). 131–138. 46 indexed citations
19.
Cesarone, M R, Gianni Belcaro, Peter Rohdewald, et al.. (2006). Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol®: A Prospective, Controlled Study. Angiology. 57(5). 569–576. 31 indexed citations
20.
Cesarone, M R, Gianni Belcaro, L Pellegrini, et al.. (2005). HR, 0-(Beta-Hydroxyethyl)-Rutosides; (Venoruton®): Rapid Relief of Signs/Symptoms in Chronic Venous Insufficiency and Microangiopathy: A Prospective, Controlled Study. Angiology. 56(2). 165–172. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026